OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CRISPR-Cas9 in Alzheimer’s disease: Therapeutic trends, modalities, and challenges
Leena Chacko, Anupama Chaudhary, Birbal Singh, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 8, pp. 103652-103652
Closed Access | Times Cited: 8
Leena Chacko, Anupama Chaudhary, Birbal Singh, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 8, pp. 103652-103652
Closed Access | Times Cited: 8
Showing 8 citing articles:
Screening Techniques for Drug Discovery in Alzheimer’s Disease
Sandra Maniam, Subashani Maniam
ACS Omega (2024) Vol. 9, Iss. 6, pp. 6059-6073
Open Access | Times Cited: 10
Sandra Maniam, Subashani Maniam
ACS Omega (2024) Vol. 9, Iss. 6, pp. 6059-6073
Open Access | Times Cited: 10
APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets
Sònia Sirisi, Érika Sánchez‐Aced, Olivia Belbin, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Sònia Sirisi, Érika Sánchez‐Aced, Olivia Belbin, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects
Mohamad Sultan Khan, Nousheen Qureshi, Rehan Khan, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Mohamad Sultan Khan, Nousheen Qureshi, Rehan Khan, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Advances and Challenges of Sensing in Water Using CRISPR-Cas Technology
Moein Safarkhani, Bahareh Farasati Far, Suhyeon Kim, et al.
ACS Biomaterials Science & Engineering (2024)
Closed Access | Times Cited: 1
Moein Safarkhani, Bahareh Farasati Far, Suhyeon Kim, et al.
ACS Biomaterials Science & Engineering (2024)
Closed Access | Times Cited: 1
Successful Gene Editing of Apolipoprotein E4 to E3 in Brain of Alzheimer Model Mice After a Single IV Dose of Synthetic Exosome-Delivered CRISPR
Bruce Teter, Jesus Campagna, Chunni Zhu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Bruce Teter, Jesus Campagna, Chunni Zhu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Dysregulation of energy metabolism in Alzheimer's disease
Yue Yuan, Gang Zhao, Yang Zhao
Journal of Neurology (2024) Vol. 272, Iss. 1
Open Access | Times Cited: 1
Yue Yuan, Gang Zhao, Yang Zhao
Journal of Neurology (2024) Vol. 272, Iss. 1
Open Access | Times Cited: 1
Engineering Microbes for Health and Therapeutic Applications
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, et al.
(2024), pp. 459-476
Closed Access
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, et al.
(2024), pp. 459-476
Closed Access
Review on pathogenesis and treatment of Alzheimer's disease
Jinxia Cai, Yanqing Liu, Haojun Fan
Developmental Dynamics (2024)
Open Access
Jinxia Cai, Yanqing Liu, Haojun Fan
Developmental Dynamics (2024)
Open Access
